- Home
- TRVI vs BSM Comparison
TRVI vs BSM Comparison
Compare TRVI & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | BSM |
|---|---|---|
| Founded | 2011 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.0B |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TRVI | BSM |
|---|---|---|
| Price | $17.23 | $14.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 1 |
| Target Price | ★ $21.55 | $14.00 |
| AVG Volume (30 Days) | ★ 1.4M | 345.8K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 8.40% |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $469,919,000.00 |
| Revenue This Year | N/A | $11.03 |
| Revenue Next Year | N/A | $9.63 |
| P/E Ratio | ★ N/A | $12.82 |
| Revenue Growth | N/A | ★ 8.35 |
| 52 Week Low | $6.98 | $12.32 |
| 52 Week High | $20.22 | $15.49 |
Technical Indicators
Market Signals| Indicator | TRVI | BSM |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 51.57 |
| Support Level | $16.24 | $14.54 |
| Resistance Level | $19.30 | $14.76 |
| Average True Range (ATR) | 0.75 | 0.24 |
| MACD | -0.19 | -0.00 |
| Stochastic Oscillator | 26.70 | 53.13 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About BSM Black Stone Minerals L.P.
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests. The company owns mineral interests in approximately 16.9 million gross acres.